Trial Profile
Comparing Lopinavir/Ritonavir and Atazanavir plus Ritonavir in HIV-1 infected patients in routine clinical practice in Buenos Aires
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 26 Mar 2018
Price :
$35
*
At a glance
- Drugs Lopinavir/ritonavir (Primary) ; Atazanavir; Ritonavir
- Indications HIV-1 infections
- Focus Therapeutic Use
- 26 Mar 2018 New trial record
- 04 Mar 2018 Results presented at the 18th International Congress on Infectious Diseases